Therefore, the activation of IL2–STAT5 signaling observed in our dataset may reflect an endogenous immune regulatory process, consistent with the mechanisms targeted by IL-2–based immunotherapy after myocardial infarction. Here, IL2 is linked to myocardial infarction.